Excessive erythrocytosis compromises the blood-endothelium interface in erythropoietin-overexpressing mice

Journal of Physiology

Volumn 589, Issue 21, 2011, Pages 5181-5192

  Richter, Vincent ^a   Savery, Michele D ^b   Gassmann, Max ^c   Baum, Oliver ^d   Damiano, Edward R ^b   Pries, Axel R ^a,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Boston University   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VISCOSITY; CONTROLLED STUDY; ERYTHROCYTOSIS; FEMALE; GLYCOCALYX; HEMATOCRIT; HEMODYNAMICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; WILD TYPE;

ANIMALS; BLOOD FLOW VELOCITY; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN; HEART RATE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROCIRCULATION; MUSCLE, SKELETAL; POLYCYTHEMIA; VASCULAR RESISTANCE;

EID: 80055017427     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.209262     Document Type: Article

References (56)

1. Assaf SA, Benirschke K & Chmait RH (2011). Spontaneous twin anemia-polycythemia sequence complicated by recipient placental vascular thrombosis and hydrops fetalis. J Matern Fetal Neonatal Med 24, 549-552.
2. Bogdanova A, Mihov D, Lutz H, Saam B, Gassmann M & Vogel J (2007). Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin. Blood 110, 762-769.
3. Brown DW, Giles WH & Croft JB (2001). Hematocrit and the risk of coronary heart disease mortality. Am Heart J 142, 657-663.
4. Cokelet GR (1999). Poiseuille Award Lecture. Viscometric, in vitro and in vivo blood viscosity relationships: how are they related? Biorheology 36, 343-358.
5. Constantinescu AA, Vink H & Spaan JA (2001). Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. Am J Physiol Heart Circ Physiol 280, H1051-1057.
6. Damiano ER, Long DR & Smith ML (2004). Estimation of viscosity profiles using velocimetry data from parallel flow of linearly viscous fluids: application to microvascular haemodynamics. J Fluid Mech 512, 1-19.
7. Damiano ER & Stace TM (2002). A mechano-electrochemical model of radial deformation of the capillary glycocalyx. Biophys J 82, 1153-1175.
8. Damiano ER & Stace TM (2005). Flow and deformation of the capillary glycocalyx in the wake of a leukocyte. Phys Fluids 17, 1153-1175.
9. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
10. Frietsch T, Gassmann M, Groth G, Waschke KF, Vogel J, Cabrales P, Vajkoczi P, Dorn-Beineke A, Intaglietta M & Kerger H (2007a). Excessive erythrocytosis does not elevate capillary oxygen delivery in subcutaneous mouse tissue. Microcirculation 14, 111-123.
11. Frietsch T, Maurer MH, Vogel J, Gassmann M, Kuschinsky W & Waschke KF (2007b). Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin overexpressing transgenic mice with excessive erythrocytosis. J Cereb Blood Flow Metab 27, 469-476.
12. Gagnon DR, Zhang TJ, Brand FN & Kannel WB (1994). Hematocrit and the risk of cardiovascular disease - the Framingham study: a 34-year follow-up. Am Heart J 127, 674-682.
13. Goubali A, Voukiklaris G, Kritsikis S, Viliotou F & Stamatis D (1995). Relation of hematocrit values to coronary heart disease, arterial hypertension, and respiratory impairment in occupational and population groups of the Athens area. Angiology 46, 719-725.
14. Harrison MJ, Pollock S, Kendall BE & Marshall J (1981). Effect of haematocrit on carotid stenosis and cerebral infarction. Lancet 2, 114-115.
15. Heinicke K, Baum O, Ogunshola OO, Vogel J, Stallmach T, Wolfer DP, Keller S, Weber K, Wagner PD, Gassmann M & Djonov V (2006). Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am J Physiol Regul Integr Comp Physiol 291, R947-956.
16. Henry CB & Duling BR (2000). TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 279, H2815-2823.
17. Jelkmann W (2011). Regulation of erythropoietin production. J Physiol 589, 1251-1258.
18. Kim S, Kong RL, Popel AS, Intaglietta M & Johnson PC (2007). Temporal and spatial variations of cell-free layer width in arterioles. Am J Physiol Heart Circ Physiol 293, H1526-1535.
19. Lipowsky HH & Firrell JC (1986). Microvascular hemodynamics during systemic hemodilution and hemoconcentration. Am J Physiol Heart Circ Physiol 250, H908-922.
20. Long DS, Smith ML, Pries AR, Ley K & Damiano ER (2004). Microviscometry reveals reduced blood viscosity and altered shear rate and shear stress profiles in microvessels after hemodilution. Proc Natl Acad Sci U S A 101, 10060-10065.
21. Lowe GD & Forbes CD (1985). Platelet aggregation, haematocrit, and fibrinogen. Lancet 1, 395-396.
22. Maeda N, Suzuki Y, Tanaka J & Tateishi N (1996). Erythrocyte flow and elasticity of microvessels evaluated by marginal cell-free layer and flow resistance. Am J Physiol Heart Circ Physiol 271, H2454-2461.
23. Mulivor AW & Lipowsky HH (2004). Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 286, H1672-1680.
24. Neunteufl T, Heher S, Stefenelli T, Pabinger I & Gisslinger H (2001). Endothelial dysfunction in patients with polycythaemia vera. Br J Haematol 115, 354-359.
25. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, Holleman F, Hoekstra JB, Vink H, Kastelein JJ & Stroes ES (2006). Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55, 480-486.
26. Ogunshola OO, Djonov V, Staudt R, Vogel J & Gassmann M (2006). Chronic excessive erythrocytosis induces endothelial activation and damage in mouse brain. Am J Physiol Regul Integr Comp Physiol 290, R678-684.
27. Platts SH, Linden J & Duling BR (2003). Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation. Am J Physiol Heart Circ Physiol 284, H2360-2367.
28. Potter DR & Damiano ER (2008). The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ Res 102, 770-776.
29. Potter DR, Jiang J & Damiano ER (2009). The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ Res 104, 1318-1325.
30. Pries AR, Neuhaus D & Gaehtgens P (1992). Blood viscosity in tube flow: dependence on diameter and hematocrit. Am J Physiol Heart Circ Physiol 263, H1770-1778.
31. Pries AR, Schonfeld D, Gaehtgens P, Kiani MF & Cokelet GR (1997a). Diameter variability and microvascular flow resistance. Am J Physiol Heart Circ Physiol 272, H2716-2725.
32. Pries AR & Secomb TW (2005). Microvascular blood viscosity in vivo and the endothelial surface layer. Am J Physiol Heart Circ Physiol 289, H2657-2664.
33. Pries AR, Secomb TW & Gaehtgens P (2000). The endothelial surface layer. Pflugers Arch 440, 653-666.
34. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF & Gaehtgens P (1994). Resistance to blood flow in microvessels in vivo. Circ Res 75, 904-915.
35. Pries AR, Secomb TW, Jacobs H, Sperandio M, Osterloh K & Gaehtgens P (1997b). Microvascular blood flow resistance: role of endothelial surface layer. Am J Physiol Heart Circ Physiol 273, H2272-2279.
36. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA & oude Egbrink MG (2007). The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 454, 345-359.
37. Richardson TQ & Guyton AC (1959). Effects of polycythemia and anemia on cardiac output and other circulatory factors. Am J Physiol 197, 1167-1170.
38. Rubio-Gayosso I, Platts SH & Duling BR (2006). Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 290, H2247-2256.
39. Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C, Wagner K, Labugger R, Kelm M, Noll G, Rulicke T, Shaw S, Lindberg RL, Rodenwaldt B, Lutz H, Bauer C, Luscher TF & Gassmann M (2000). Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A 97, 11609-11613.
40. Savery MD & Damiano ER (2008). The endothelial glycocalyx is hydrodynamically relevant in arterioles throughout the cardiac cycle. Biophys J 95, 1439-1447.
41. Schuler B, Arras M, Keller S, Rettich A, Lundby C, Vogel J & Gassmann M (2010). Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice. Proc Natl Acad Sci U S A 107, 419-423.
42. Schunkert H, Koenig W, Brockel U, Muscholl MW, Doring A, Riegger GA & Hense HW (2000). Haematocrit profoundly affects left ventricular diastolic filling as assessed by Doppler echocardiography. J Hypertens 18, 1483-1489.
43. Secomb TW, Hsu R & Pries AR (2002). Blood flow and red blood cell deformation in nonuniform capillaries: effects of the endothelial surface layer. Microcirculation 9, 189-196.
44. Skretteberg PT, Bodegard J, Kjeldsen SE, Erikssen G, Thaulow E, Sandvik L & Erikssen JE (2010). Interaction between inflammation and blood viscosity predicts cardiovascular mortality. Scand Cardiovasc J 44, 107-112.
45. Smith ML, Long DS, Damiano ER & Ley K (2003). Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys J 85, 637-645.
46. Spivak JL (2002). Polycythemia vera: myths, mechanisms, and management. Blood 100, 4272-4290.
47. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr & Lerman A (2000). Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101, 948-954.
48. van den Berg BM, Spaan JA, Rolf TM & Vink H (2006). Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation. Am J Physiol Heart Circ Physiol 290, H915-920.
49. Vink H, Constantinescu AA & Spaan JA (2000). Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101, 1500-1502.
50. Vink H & Duling BR (1996). Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79, 581-589.
51. Vink H & Duling BR (2000). Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 278, H285-289.
52. Vogel J & Gassmann M (2011). Erythropoietic and non-erythropoietic functions of erythropoietin (Epo) in mouse models. J Physiol 589, 1259-1264.
53. Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aulmann M, Frietsch T, Schmid-Schonbein H, Kuschinsky W & Gassmann M (2003). Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood 102, 2278-2284.
54. Wagner KF, Katschinski DM, Hasegawa J, Schumacher D, Meller B, Gembruch U, Schramm U, Jelkmann W, Gassmann M & Fandrey J (2001). Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood 97, 536-542.
55. Wannamethee G, Perry IJ & Shaper AG (1994). Haematocrit, hypertension and risk of stroke. J Intern Med 235, 163-168.
56. Weinbaum S, Zhang X, Han Y, Vink H & Cowin SC (2003). Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci U S A 100, 7988-7995.